Investor Presentaiton
Build depth across our therapeutic areas
Oncology
Extend 10 leadership
SC nivolumab,
Opdualag, & next
generation assets
Cardiovascular
Deepen leadership in
cardiomyopathies &
heart failure
Diversification
beyond 10
Ill Bristol Myers Squibb™
Expand expertise in
thrombotic diseases
Hematology
Immunology
Neuroscience
Extend leadership
across the Multiple
Myeloma treatment
paradigm
Broaden portfolio
across leukemias,
lymphomas and
non-malignant
hematologic diseases
Establish new
standards of care in
pulmonology
Strengthen presence
in dermatology,
rheumatology, &
gastrointestinal
disorders
Rapidly advance Cell
Therapy into
immunologic diseases
Build a diverse
pipeline across
neurodegenerative &
neuroinflammation
diseases
Advance promising
clinical assets in
Alzheimer's Disease
& ALS
Not for Product Promotional Use
10View entire presentation